FOXO TECHNOLOGIES INC. Operating Cash Flow
FOXO TECHNOLOGIES INC. (FOXO) reported Operating Cash Flow of -$279.22 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $298.67K.
- FOXO TECHNOLOGIES INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$577.90K.
- FOXO TECHNOLOGIES INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$104.03K.
- FOXO TECHNOLOGIES INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$44.78K, a 107.76% decline year-over-year.
- FOXO TECHNOLOGIES INC. net cash provided by (used in) operating activities for fiscal 2025 was -$3.87M.
- FOXO TECHNOLOGIES INC. net cash provided by (used in) operating activities for fiscal 2024 was -$2.84M.
- FOXO TECHNOLOGIES INC. net cash provided by (used in) operating activities for fiscal 2023 was -$6.65M.
- FOXO TECHNOLOGIES INC. net cash provided by (used in) operating activities for fiscal 2022 was -$23.76M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 8 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $298.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$279.22K 10-Q · filed 2026-08-14 | -$383.25K derived: sum of 3 quarters · filed 2026-08-14 | -$428.04K derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2026-03-31 | -$577.90K 10-Q · filed 2026-05-15 | -$681.93K derived: sum of 2 quarters · filed 2026-05-15 | -$726.71K derived: sum of 3 quarters · filed 2026-05-15 | -$3.11M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-12-31 | -$104.03K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$148.81K derived: sum of 2 quarters · filed 2026-04-15 | -$2.53M derived: sum of 3 quarters · filed 2026-08-14 | -$3.87M 10-K · filed 2026-04-15 | |||||
| 2025-09-30 | -$44.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$2.42M derived: sum of 2 quarters · filed 2026-08-14 | -$3.76M 10-Q · filed 2025-11-10 | -$5.61M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-06-30 | -$2.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$3.72M 10-Q · filed 2026-08-14 | -$5.56M derived: sum of 3 quarters · filed 2026-08-14 | -$4.99M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-03-31 | -$1.34M 10-Q · filed 2026-05-15 | -$3.18M derived: sum of 2 quarters · filed 2026-05-15 | -$2.61M derived: sum of 3 quarters · filed 2026-05-15 | -$3.77M derived: sum of 4 quarters · filed 2026-05-15 | |||||
| 2024-12-31 | -$1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$1.27M derived: sum of 2 quarters · filed 2026-04-15 | -$2.43M derived: sum of 3 quarters · filed 2026-04-15 | -$2.84M 10-K · filed 2026-04-15 | |||||
| 2024-09-30 | $577.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$588.28K derived: sum of 2 quarters · filed 2025-11-10 | -$994.58K 10-Q · filed 2025-11-10 | -$995.00K 10-Q · filed 2024-11-19 | -$1.47M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | -$1.17M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2025-08-19 | -$1.57M 10-Q · filed 2025-08-19 | $551.00K 10-Q · filed 2024-08-19 | -$2.05M derived: sum of 3 quarters · filed 2025-08-19 | -$2.92M derived: sum of 4 quarters · filed 2025-08-19 | ||||
| 2024-03-31 | -$406.30K 10-Q/A · filed 2025-08-19 | $1.72M 10-Q · filed 2024-06-28 | -$886.36K derived: sum of 2 quarters · filed 2025-08-19 | -$1.75M derived: sum of 3 quarters · filed 2025-08-19 | -$3.69M derived: sum of 4 quarters · filed 2025-08-19 | ||||
| 2023-12-31 | -$480.06K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$1.35M derived: sum of 2 quarters · filed 2025-04-15 | -$3.29M derived: sum of 3 quarters · filed 2025-04-15 | -$6.65M 10-K · filed 2025-04-15 | -$6.64M 10-K · filed 2024-06-06 | ||||
| 2023-09-30 | -$865.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | -$2.81M derived: sum of 2 quarters · filed 2024-11-19 | -$6.17M 10-Q · filed 2024-11-19 | -$10.69M derived: sum of 4 quarters · filed 2024-11-19 | |||||
| 2023-06-30 | -$1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | -$5.30M 10-Q · filed 2024-08-19 | -$9.83M derived: sum of 3 quarters · filed 2024-08-19 | -$14.87M derived: sum of 4 quarters · filed 2024-08-19 | |||||
| 2023-03-31 | -$3.36M 10-Q · filed 2024-06-28 | -$7.89M derived: sum of 2 quarters · filed 2024-06-28 | -$12.93M derived: sum of 3 quarters · filed 2024-06-28 | -$19.93M derived: sum of 4 quarters · filed 2024-06-28 | |||||
| 2022-12-31 | -$4.53M derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-06-06 | -$9.57M derived: sum of 2 quarters · filed 2024-06-06 | -$16.57M derived: sum of 3 quarters · filed 2024-06-06 | -$23.76M 10-K · filed 2024-06-06 | |||||
| 2022-09-30 | -$5.04M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-06-04 | -$12.05M derived: sum of 2 quarters · filed 2024-06-04 | -$19.23M 10-Q/A · filed 2024-06-04 | -$22.54M derived: sum of 4 quarters · filed 2024-06-04 | |||||
| 2022-06-30 | -$7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$14.19M 10-Q · filed 2023-08-10 | -$1.20M 10-Q · filed 2022-08-12 | -$17.50M derived: sum of 3 quarters · filed 2023-08-10 | -$28.99M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$7.19M 10-Q · filed 2023-05-11 | -$644.90K 10-Q · filed 2022-05-16 | -$10.49M derived: sum of 2 quarters · filed 2023-05-11 | -$21.99M derived: sum of 3 quarters · filed 2023-05-11 | -$22.13M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$3.31M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$14.80M derived: sum of 2 quarters · filed 2023-03-31 | -$14.94M derived: sum of 3 quarters · filed 2023-03-31 | -$15.05M 10-K · filed 2023-03-31 | -$779.31K 10-K · filed 2022-03-07 | ||||
| 2021-09-30 | -$11.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-21 | -$11.63M derived: sum of 2 quarters · filed 2022-11-21 | -$11.75M 10-Q · filed 2022-11-21 | -$408.01K 10-Q · filed 2021-11-15 | |||||
| 2021-06-30 | -$139.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$253.38K 10-Q · filed 2022-08-12 | |||||||
| 2021-03-31 | -$114.23K 10-Q · filed 2022-05-16 | ||||||||
| 2020-12-31 | -$481.43K 10-K · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |